| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
Stock Code: IPD
Listing Date: 2007-10-24 00:00:00
Website: http://www.impedimed.com
Industry: Health Care Equipment & Services
Principal Activities:
The development and sale internationally of medical devices for diagnosing and monitoring human disorders and diseases.
Address:
, 50 Parker Court, Unit 1,
PINKENBA
QLD 4008
Phone: (07) 3860 3700
Fax: (07) 3260 1225
Executives & Directors
Mr Melvyn (Mel) John Bridges, Chairman, Non Exec. Director
Mr Greg Brown, Managing Director, CEO
Mr James (Jim) Hazel, Director, Non Exec. Director
Dr Cherrell Hirst, Director, Non Exec. Director
Mr Martin Kriewaldt, Director, Non Exec. Director
Dr Michael Panaccio, Director, Non Exec. Director
Mr Stephen Denaro, Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon: 
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
| Event | Date/time | |
|---|---|---|
| IPD - Healthy Investment eConference - Mr Greg Brown, Managing Director, CEO |
|
Wed, 1 Jul 2009 12:30pm |
IPD - Annual General Meeting Overview and Operations Update - Mr Greg Brown, CEO and MD
|
|
Thu, 13 Nov 2008 9:45am |
|
IPD - Quarterly Activities Update - Mr Greg Brown, CEO and MD
|
|
Fri, 1 Aug 2008 1:00pm |
|
IPD - Company Update from US - Mr Greg Brown, CEO and MD
|
|
Mon, 5 May 2008 3:30pm |
|
IPD - Completes US Acquisition of Xitron Technologies - Mr Greg Brown, CEO and MD
|
|
Tue, 30 Oct 2007 8:30am |
| Annual General Meeting | Mon, 23 Nov 2009 4:30pm |
|
| Full Year Results | Fri, 28 Aug 2009 | |
| Interim Results | Tue, 24 Feb 2009 11:00pm |
|
| Annual General Meeting | Fri, 31 Oct 2008 11:00am |
|
| EGM | Mon, 21 Apr 2008 4:00pm |
|
| EGM | Mon, 21 Apr 2008 4:00pm |
| Change in substantial holding from WIG | Wed, 17 Mar 2010 |
| Shareholder Presentation Update | Tue, 16 Mar 2010 |
| Walton Taylor appointed Medical Director | Wed, 10 Mar 2010 |
| United States Reimbursement Coding | Mon, 8 Mar 2010 |
| Trading Halt | Fri, 5 Mar 2010 |
| 31 December 2009 Half Year Results Appendix 4D | Wed, 24 Feb 2010 |
| 10 Year Follow Up Study | Fri, 12 Feb 2010 |
| IPO Options Listing Rule 6.22 | Thu, 11 Feb 2010 |
| Appendix 3B | Thu, 11 Feb 2010 |
| Appendix 4C - quarterly | Fri, 29 Jan 2010 |
| 3B Quotation of Exercised Options | Thu, 24 Dec 2009 |
| Share Registry Address Change | Tue, 22 Dec 2009 |
| Appointment of Chinese Distributor | Tue, 15 Dec 2009 |
| Xitron Matter | Tue, 15 Dec 2009 |
| Release of Restricted Securities on 31 December 2009 | Mon, 14 Dec 2009 |
| University Study supports ImpediMed Device | Tue, 24 Nov 2009 |
| AGM CEO Presentation | Mon, 23 Nov 2009 |
| AGM Voting Results | Mon, 23 Nov 2009 |
| American Medical Association Category 1 CPT Filing | Thu, 12 Nov 2009 |
| ImpediMed appoints a Chief Financial Officer | Wed, 11 Nov 2009 |
| Vice President of Global Finance Appointment | Fri, 6 Nov 2009 |
| Change in Substantial Holding - Starfish Deemed Interest | Thu, 5 Nov 2009 |
| Change of Director`s Interest Notice - M Panaccio (deemed) | Thu, 5 Nov 2009 |
| Cease Substantial Shareholder in itself re Escrow Release | Wed, 28 Oct 2009 |
| Quarterly Cashflow Report | Tue, 27 Oct 2009 |
| Notice of Annual General Meeting/Proxy Form | Mon, 26 Oct 2009 |
| Appendix 3B Release of Escrow Shares | Mon, 26 Oct 2009 |
| BIS Suggested as Gold Standard | Fri, 23 Oct 2009 |
| US Insurer review of Lymphoedema Management | Thu, 22 Oct 2009 |
| VP Quality and Regulatory Appointment | Wed, 21 Oct 2009 |
| Escrow Share Release | Fri, 9 Oct 2009 |
| Company Secretary Appointment/Resignation | Fri, 11 Sep 2009 |
| Response to ASX query re Appendix 3Z | Mon, 31 Aug 2009 |
| FY2009 Positive Year for Acceptance and adoption of L-Dex | Fri, 28 Aug 2009 |
| Annual Report to shareholders - 2009 | Fri, 28 Aug 2009 |
| Appendix 4E - Period Ended 30 June 2009 | Fri, 28 Aug 2009 |
| Change of Director`s Interest Notice - M Panaccio (deemed) | Fri, 28 Aug 2009 |
| Change in substantial holding - Starfish deemed interest | Fri, 28 Aug 2009 |
| Change in substantial holding - ImpediMed deemed in itself | Fri, 28 Aug 2009 |
| Details of Share Registry address - Change | Fri, 21 Aug 2009 |
| CFO Role to relocate to US | Tue, 18 Aug 2009 |
| Appendix 3B - Staff and Consultant Performance Shares | Fri, 7 Aug 2009 |
| Company Update - Financial Year Ended 30th June 2009 | Fri, 31 Jul 2009 |
| Appendix 4C - quarterly - Qtr Ended 30th June 2009 | Fri, 31 Jul 2009 |
| North Carolina legislation breaks new ground for lymphoedema | Tue, 28 Jul 2009 |
| Uni Sydney Publication- L-Dex most suited to early detection | Tue, 14 Jul 2009 |
| Pending release of listed shares from escrow | Tue, 14 Jul 2009 |
| L-Dex adopted at Univ College London Hospital and Blackburn | Fri, 10 Jul 2009 |
| Ceasing to be a substantial holder - Versant | Wed, 8 Jul 2009 |
| Becoming a substantial holder | Tue, 7 Jul 2009 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.